mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
isoliquiritigenin |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.1 |
mRNA |
LAQ824 |
GDSC1000 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
BAY 61-3606 |
GDSC1000 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.1 |
mRNA |
hyperforin |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.1 |
mRNA |
BRD-K66532283 |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.1 |
mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
-0.051 |
0.1 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.1 |